Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and ...
Objective: Using a qualitative approach, our study aims to understand the perceptions of clinical research staff (CRS) of this transition and its impact on delivering a patient-centered experience.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback